NCT00908960 - Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

October 31, 2012

Conditions

Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer

Interventions

DRUG

Enoxaparin

Trial Locations (5)

University of Southern California-Keck School of Medicine, Los Angeles

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

VA Boston Healthcare System, Boston

Mass General/North Shore Cancer Center, Danvers